title: Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control.
abstract: The aim was to evaluate changes in insulin requirements from onset of continuous subcutaneous insulin infusion (CSII) until glucose optimization in type 1 diabetes and to determine patient characteristics to be considered when CSII is implemented. We retrospectively analyzed 74 type 1 diabetic patients over a follow-up of 5 months after starting CSII. Patients without a decrease in HbA1c levels at the end of follow-up were excluded. We compared total daily doses (TDD), basal/bolus distribution, basal diurnal/nocturnal proportion, number of basal segments, and HbA1c levels in relation to sex, age, body mass index (BMI), diabetes duration, and indication for CSII. At follow-up, HbA1c decreased by 0.75%, TDD decreased by 18%, basal rate was 60% of TDD, and diurnal basal rate was 60% of total basal rate. Insulin requirements were higher in males and in obese patients. Female patients and patients with longer diabetes duration showed a higher percentage of basal insulin. The number of basal segments was 4.9 ± 2.9. Basal requirements were higher in the second half of the nocturnal period. The dawn phenomenon was more relevant in men. Improvements in glycemic control were more marked in younger patients, in patients with higher HbA1c, in patients using more basal segments, and in patients initiating CSII for glucose control before pregnancy. Sex, diabetes duration, and BMI should be considered when initiating CSII. Our findings may help clinicians in clinical decision making regarding CSII therapy.
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain EDUAB-HSP. Barcelona, Spain achicob@santpau.cat.
authors.forename: Ana
authors.initials: A
authors.lastname: Chico
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: Diana
authors.initials: D
authors.lastname: Tundidor
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: Lluis
authors.initials: L
authors.lastname: Jordana
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: Ignasi
authors.initials: I
authors.lastname: Saigi
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Maria
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain EDUAB-HSP. Barcelona, Spain.
authors.forename: Rosa
authors.initials: R
authors.lastname: Corcoy
authors.affiliation: Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain EDUAB-HSP. Barcelona, Spain.
authors.forename: A de
authors.initials: AD
authors.lastname: Leiva
keywords: glycated hemoglobin; insulin pump; type 1 diabetes